PubMed:19240270
Annnotations
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1199-1203 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
T2 | 1199-1203 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
T3 | 1208-1212 | https://glytoucan.org/Structures/Glycans/G37184KW | denotes | GD1b |
T4 | 1208-1212 | https://glytoucan.org/Structures/Glycans/G97612UN | denotes | GD1b |
T5 | 1217-1220 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T6 | 1217-1220 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T7 | 1225-1229 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
T8 | 1225-1229 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1199-1203 | Glycan_Motif | denotes | GD1a | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE |
T3 | 1208-1212 | Glycan_Motif | denotes | GD1b | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G97612UN|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G37184KW |
T5 | 1217-1220 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T7 | 1225-1229 | Glycan_Motif | denotes | GD1a | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G69277LC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46677TE |
PMID_GLOBAL
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 67-90 | DiseaseOrPhenotypicFeature | denotes | Guillain-Barré syndrome | 0016218 |
T2 | 124-147 | DiseaseOrPhenotypicFeature | denotes | Guillain-Barré syndrome | 0016218 |
T3 | 149-152 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T5 | 182-204 | DiseaseOrPhenotypicFeature | denotes | polyradiculoneuropathy | 0006915 |
T6 | 211-214 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
T7 | 227-239 | DiseaseOrPhenotypicFeature | denotes | quadriplegia | 0001590 |
T8 | 241-250 | DiseaseOrPhenotypicFeature | denotes | Infection | 0005550 |
T9 | 536-546 | DiseaseOrPhenotypicFeature | denotes | infectious | 0005550 |
T10 | 568-571 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
T11 | 579-582 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T13 | 628-638 | DiseaseOrPhenotypicFeature | denotes | infectious | 0005550 |
T14 | 779-782 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T16 | 991-994 | DiseaseOrPhenotypicFeature | denotes | PNS | 0018215 |
T17 | 1056-1059 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T19 | 1107-1110 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T21 | 1390-1393 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T23 | 1578-1581 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T25 | 1647-1650 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T27 | 1658-1661 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T29 | 1682-1697 | DiseaseOrPhenotypicFeature | denotes | genetic disease | 0003847 |
T30 | 1802-1805 | DiseaseOrPhenotypicFeature | denotes | GBS | 0007691|0016218 |
T32 | 1826-1835 | DiseaseOrPhenotypicFeature | denotes | infection | 0005550 |
Glycosmos6-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 867-883 | http://purl.obolibrary.org/obo/MAT_0000099 | denotes | peripheral nerve |
T2 | 964-989 | http://purl.obolibrary.org/obo/MAT_0000338 | denotes | peripheral nervous system |
T3 | 975-989 | http://purl.obolibrary.org/obo/MAT_0000026 | denotes | nervous system |
T4 | 991-994 | http://purl.obolibrary.org/obo/MAT_0000338 | denotes | PNS |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-123 | Sentence | denotes | Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. |
TextSentencer_T2 | 124-240 | Sentence | denotes | Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. |
TextSentencer_T3 | 241-425 | Sentence | denotes | Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. |
TextSentencer_T4 | 426-583 | Sentence | denotes | Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. |
TextSentencer_T5 | 584-764 | Sentence | denotes | Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. |
TextSentencer_T6 | 765-916 | Sentence | denotes | Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. |
TextSentencer_T7 | 917-1069 | Sentence | denotes | Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. |
TextSentencer_T8 | 1070-1279 | Sentence | denotes | Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. |
TextSentencer_T9 | 1280-1503 | Sentence | denotes | The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. |
TextSentencer_T10 | 1504-1651 | Sentence | denotes | Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. |
TextSentencer_T11 | 1652-1836 | Sentence | denotes | While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection. |
T1 | 0-123 | Sentence | denotes | Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. |
T2 | 124-240 | Sentence | denotes | Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. |
T3 | 241-425 | Sentence | denotes | Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. |
T4 | 426-583 | Sentence | denotes | Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. |
T5 | 584-764 | Sentence | denotes | Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. |
T6 | 765-916 | Sentence | denotes | Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. |
T7 | 917-1069 | Sentence | denotes | Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. |
T8 | 1070-1279 | Sentence | denotes | Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. |
T9 | 1280-1503 | Sentence | denotes | The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. |
T10 | 1504-1651 | Sentence | denotes | Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. |
T11 | 1652-1836 | Sentence | denotes | While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection. |
T1 | 0-123 | Sentence | denotes | Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. |
T2 | 124-240 | Sentence | denotes | Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. |
T3 | 241-425 | Sentence | denotes | Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. |
T4 | 426-583 | Sentence | denotes | Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. |
T5 | 584-764 | Sentence | denotes | Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. |
T6 | 765-916 | Sentence | denotes | Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. |
T7 | 917-1069 | Sentence | denotes | Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. |
T8 | 1070-1279 | Sentence | denotes | Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. |
T9 | 1280-1503 | Sentence | denotes | The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. |
T10 | 1504-1651 | Sentence | denotes | Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. |
T11 | 1652-1836 | Sentence | denotes | While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection. |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1199-1203 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
T2 | 1199-1203 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
T3 | 1208-1212 | https://glytoucan.org/Structures/Glycans/G37184KW | denotes | GD1b |
T4 | 1208-1212 | https://glytoucan.org/Structures/Glycans/G97612UN | denotes | GD1b |
T5 | 1217-1220 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T6 | 1217-1220 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T7 | 1225-1229 | https://glytoucan.org/Structures/Glycans/G46677TE | denotes | GD1a |
T8 | 1225-1229 | https://glytoucan.org/Structures/Glycans/G69277LC | denotes | GD1a |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1199-1203 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
T2 | 1208-1212 | http://www.glycoepitope.jp/epitopes/EP0059 | denotes | GD1b |
T3 | 1217-1220 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T4 | 1225-1229 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
GlycoBiology-PACDB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 283-303 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC257,LEC564 | denotes | Campylobacter jejuni |
_T2 | 317-339 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC075,LEC084,LEC085,LEC405,LEC439,LEC523 | denotes | Haemophilus influenzae |
_T3 | 317-339 | http://acgg.asia/db/diseases/pacdb/lec?ids=LEC590 | denotes | Haemophilus influenzae |
ICD10
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 67-90 | http://purl.bioontology.org/ontology/ICD10/G61.0 | denotes | Guillain-Barré syndrome |
T2 | 124-147 | http://purl.bioontology.org/ontology/ICD10/G61.0 | denotes | Guillain-Barré syndrome |
T3 | 975-982 | http://purl.bioontology.org/ontology/ICD10/R45.0 | denotes | nervous |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 16-26 | FMAID:167180 | denotes | antibodies |
_T2 | 262-271 | FMAID:67498 | denotes | organisms |
_T3 | 262-271 | FMAID:166081 | denotes | organisms |
_T4 | 387-391 | FMAID:214734 | denotes | main |
_T5 | 426-445 | FMAID:82742 | denotes | Lipooligosaccharide |
_T6 | 426-445 | FMAID:196731 | denotes | Lipooligosaccharide |
_T7 | 452-457 | FMAID:198663 | denotes | genes |
_T8 | 501-512 | FMAID:82816 | denotes | ganglioside |
_T9 | 501-512 | FMAID:196811 | denotes | ganglioside |
_T10 | 553-562 | FMAID:166081 | denotes | organisms |
_T41 | 964-974 | FMAID:222825 | denotes | peripheral |
_T11 | 553-562 | FMAID:67498 | denotes | organisms |
_T12 | 617-624 | FMAID:146300 | denotes | surface |
_T13 | 617-624 | FMAID:50594 | denotes | surface |
_T14 | 653-664 | FMAID:82816 | denotes | ganglioside |
_T15 | 653-664 | FMAID:196811 | denotes | ganglioside |
_T16 | 677-689 | FMAID:72550 | denotes | neural cells |
_T17 | 677-689 | FMAID:171175 | denotes | neural cells |
_T18 | 677-689 | FMAID:86667 | denotes | neural cells |
_T19 | 677-689 | FMAID:174560 | denotes | neural cells |
_T20 | 677-689 | FMAID:201593 | denotes | neural cells |
_T21 | 677-689 | FMAID:201610 | denotes | neural cells |
_T22 | 677-689 | FMAID:86684 | denotes | neural cells |
_T23 | 677-689 | FMAID:70333 | denotes | neural cells |
_T24 | 684-689 | FMAID:169002 | denotes | cells |
_T25 | 684-689 | FMAID:68646 | denotes | cells |
_T26 | 791-801 | FMAID:167180 | denotes | antibodies |
_T27 | 816-828 | FMAID:82816 | denotes | gangliosides |
_T28 | 816-828 | FMAID:196811 | denotes | gangliosides |
_T29 | 867-877 | FMAID:222825 | denotes | peripheral |
_T30 | 867-877 | FMAID:74552 | denotes | peripheral |
_T31 | 867-877 | FMAID:179289 | denotes | peripheral |
_T32 | 867-883 | FMAID:163369 | denotes | peripheral nerve |
_T33 | 867-883 | FMAID:65239 | denotes | peripheral nerve |
_T34 | 867-889 | FMAID:163372 | denotes | peripheral nerve sites |
_T35 | 867-889 | FMAID:213851 | denotes | peripheral nerve sites |
_T36 | 878-883 | FMAID:227316 | denotes | nerve |
_T37 | 878-883 | FMAID:65132 | denotes | nerve |
_T38 | 878-883 | FMAID:163253 | denotes | nerve |
_T39 | 934-945 | FMAID:196811 | denotes | ganglioside |
_T40 | 934-945 | FMAID:82816 | denotes | ganglioside |
_T42 | 964-974 | FMAID:74552 | denotes | peripheral |
_T43 | 964-974 | FMAID:179289 | denotes | peripheral |
_T44 | 964-989 | FMAID:9903 | denotes | peripheral nervous system |
_T45 | 964-989 | FMAID:180410 | denotes | peripheral nervous system |
_T46 | 964-989 | FMAID:97831 | denotes | peripheral nervous system |
_T47 | 964-989 | FMAID:180407 | denotes | peripheral nervous system |
_T48 | 975-989 | FMAID:7157 | denotes | nervous system |
_T49 | 975-989 | FMAID:93586 | denotes | nervous system |
_T50 | 1127-1138 | FMAID:196811 | denotes | ganglioside |
_T51 | 1127-1138 | FMAID:82816 | denotes | ganglioside |
_T52 | 1177-1189 | FMAID:82816 | denotes | gangliosides |
_T53 | 1177-1189 | FMAID:196811 | denotes | gangliosides |
_T54 | 1261-1272 | FMAID:196811 | denotes | ganglioside |
_T55 | 1261-1272 | FMAID:82816 | denotes | ganglioside |
_T56 | 1321-1331 | FMAID:167180 | denotes | antibodies |
_T57 | 1364-1368 | FMAID:217859 | denotes | rate |
_T58 | 1372-1386 | FMAID:167180 | denotes | autoantibodies |
_T59 | 1434-1442 | FMAID:167180 | denotes | antibody |
_T60 | 1481-1493 | FMAID:197276 | denotes | carbohydrate |
_T61 | 1481-1493 | FMAID:82737 | denotes | carbohydrate |
_T62 | 1513-1524 | FMAID:196811 | denotes | ganglioside |
_T63 | 1513-1524 | FMAID:82816 | denotes | ganglioside |
_T64 | 1732-1742 | FMAID:167173 | denotes | lymphocyte |
_T65 | 1732-1742 | FMAID:167163 | denotes | lymphocyte |
_T66 | 1732-1742 | FMAID:167171 | denotes | lymphocyte |
_T67 | 1732-1742 | FMAID:62869 | denotes | lymphocyte |
_T68 | 1732-1742 | FMAID:62870 | denotes | lymphocyte |
_T69 | 1732-1742 | FMAID:167176 | denotes | lymphocyte |
_T70 | 1732-1742 | FMAID:167174 | denotes | lymphocyte |
_T71 | 1732-1742 | FMAID:62863 | denotes | lymphocyte |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 95-102 | http://purl.bioontology.org/ontology/NCBITAXON/353209 | denotes | related |
T2 | 256-261 | http://purl.bioontology.org/ontology/NCBITAXON/82411 | denotes | micro |
T3 | 283-303 | http://purl.bioontology.org/ontology/NCBITAXON/197 | denotes | Campylobacter jejuni |
T4 | 317-339 | http://purl.bioontology.org/ontology/NCBITAXON/727 | denotes | Haemophilus influenzae |
T5 | 345-360 | http://purl.bioontology.org/ontology/NCBITAXON/10358 | denotes | Cytomegalovirus |
T6 | 403-408 | http://purl.bioontology.org/ontology/STY/T051 | denotes | event |
T7 | 547-552 | http://purl.bioontology.org/ontology/NCBITAXON/82411 | denotes | micro |
T8 | 684-689 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T9 | 917-930 | http://purl.bioontology.org/ontology/NCBITAXON/691256 | denotes | Heterogeneity |
T10 | 917-930 | http://purl.bioontology.org/ontology/NCBITAXON/1113441 | denotes | Heterogeneity |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 482-491 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
T2 | 738-746 | http://purl.obolibrary.org/obo/GO_0007349 | denotes | cellular |
T3 | 738-763 | http://purl.obolibrary.org/obo/GO_0071346 | denotes | cellular immune responses |
T4 | 738-763 | http://purl.obolibrary.org/obo/GO_0002443 | denotes | cellular immune responses |
T5 | 738-763 | http://purl.obolibrary.org/obo/GO_0002449 | denotes | cellular immune responses |
T6 | 738-763 | http://purl.obolibrary.org/obo/GO_0002456 | denotes | cellular immune responses |
T7 | 747-763 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune responses |
T8 | 783-790 | http://purl.obolibrary.org/obo/GO_0032502 | denotes | develop |
T9 | 1111-1115 | http://purl.obolibrary.org/obo/GO_0004617 | denotes | sera |
T10 | 1631-1643 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
T11 | 1786-1798 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
GO-MF
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 16-26 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
T2 | 791-801 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
T3 | 1321-1331 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
T4 | 1434-1442 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 684-689 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T2 | 1699-1703 | http://purl.obolibrary.org/obo/GO_0018995 | denotes | host |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 262-271 | http://purl.obolibrary.org/obo/UBERON_0000062 | denotes | organisms |
T2 | 553-562 | http://purl.obolibrary.org/obo/UBERON_0000062 | denotes | organisms |
T3 | 878-883 | http://purl.obolibrary.org/obo/UBERON_0001021 | denotes | nerve |
T4 | 964-989 | http://purl.obolibrary.org/obo/UBERON_0000010 | denotes | peripheral nervous system |
T5 | 975-989 | http://purl.obolibrary.org/obo/UBERON_0001016 | denotes | nervous system |
DisGeNET5_gene_disease
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
19240270-10#80#98#gene3111 | 1732-1750 | gene3111 | denotes | lymphocyte antigen |
19240270-10#150#153#diseaseC0018378 | 1802-1805 | diseaseC0018378 | denotes | GBS |
80#98#gene3111150#153#diseaseC0018378 | 19240270-10#80#98#gene3111 | 19240270-10#150#153#diseaseC0018378 | associated_with | lymphocyte antigen,GBS |
GlycoBiology-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 867-883 | http://purl.obolibrary.org/obo/MAT_0000099 | denotes | peripheral nerve |
T2 | 964-989 | http://purl.obolibrary.org/obo/MAT_0000338 | denotes | peripheral nervous system |
T3 | 964-989 | http://purl.obolibrary.org/obo/MAT_0000099 | denotes | peripheral nervous system |
T4 | 975-989 | http://purl.obolibrary.org/obo/MAT_0000026 | denotes | nervous system |
GlycoBiology-Epitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-GlycoEpitope-B_T1 | 1217-1220 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
PD-GlycoEpitope-B_T2 | 1199-1203 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
PD-GlycoEpitope-B_T3 | 1225-1229 | http://www.glycoepitope.jp/epitopes/EP0056 | denotes | GD1a |
PD-GlycoEpitope-B_T4 | 1208-1212 | http://www.glycoepitope.jp/epitopes/EP0059 | denotes | GD1b |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 262-271 | http://purl.obolibrary.org/obo/UBERON_0000062 | denotes | organisms |
PD-UBERON-AE-B_T2 | 553-562 | http://purl.obolibrary.org/obo/UBERON_0000062 | denotes | organisms |
PD-UBERON-AE-B_T3 | 878-883 | http://purl.obolibrary.org/obo/UBERON_0001021 | denotes | nerve |
PD-UBERON-AE-B_T4 | 975-989 | http://purl.obolibrary.org/obo/UBERON_0001016 | denotes | nervous system |
PD-UBERON-AE-B_T5 | 964-989 | http://purl.obolibrary.org/obo/UBERON_0000010 | denotes | peripheral nervous system |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 67-90 | Disease | denotes | Guillain-Barré syndrome | http://purl.obolibrary.org/obo/MONDO_0016218 |
T2 | 124-147 | Disease | denotes | Guillain-Barré syndrome | http://purl.obolibrary.org/obo/MONDO_0016218 |
T3 | 149-152 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T4 | 182-204 | Disease | denotes | polyradiculoneuropathy | http://purl.obolibrary.org/obo/MONDO_0006915 |
T5 | 227-239 | Disease | denotes | quadriplegia | http://purl.obolibrary.org/obo/MONDO_0001590 |
T6 | 241-250 | Disease | denotes | Infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T7 | 329-339 | Disease | denotes | influenzae | http://purl.obolibrary.org/obo/MONDO_0005812 |
T8 | 536-546 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T9 | 579-582 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T10 | 628-638 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T11 | 779-782 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T12 | 991-994 | Disease | denotes | PNS | http://purl.obolibrary.org/obo/MONDO_0018215 |
T13 | 1056-1059 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T14 | 1107-1110 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T15 | 1390-1393 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T16 | 1578-1581 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T17 | 1647-1650 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T18 | 1658-1661 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T19 | 1682-1697 | Disease | denotes | genetic disease | http://purl.obolibrary.org/obo/MONDO_0003847 |
T20 | 1802-1805 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T21 | 1826-1835 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 227-239 | Phenotype | denotes | quadriplegia | HP:0002445 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1199-1203 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
T2 | 1208-1212 | Glycan | denotes | GD1b | https://api.glycosmos.org/wurcs2image/latest/png/binary/G37184KW |
T3 | 1217-1220 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T4 | 1225-1229 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 227-239 | Phenotype | denotes | quadriplegia | HP:0002445 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 67-90 | Disease | denotes | Guillain-Barré syndrome | http://purl.obolibrary.org/obo/MONDO_0016218 |
T2 | 124-147 | Disease | denotes | Guillain-Barré syndrome | http://purl.obolibrary.org/obo/MONDO_0016218 |
T3 | 149-152 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T4 | 182-204 | Disease | denotes | polyradiculoneuropathy | http://purl.obolibrary.org/obo/MONDO_0006915 |
T5 | 227-239 | Disease | denotes | quadriplegia | http://purl.obolibrary.org/obo/MONDO_0001590 |
T6 | 241-250 | Disease | denotes | Infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T7 | 329-339 | Disease | denotes | influenzae | http://purl.obolibrary.org/obo/MONDO_0005812 |
T8 | 536-546 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T9 | 579-582 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T10 | 628-638 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T11 | 779-782 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T12 | 991-994 | Disease | denotes | PNS | http://purl.obolibrary.org/obo/MONDO_0018215 |
T13 | 1056-1059 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T14 | 1107-1110 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T15 | 1390-1393 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T16 | 1578-1581 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T17 | 1647-1650 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T18 | 1658-1661 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T19 | 1682-1697 | Disease | denotes | genetic disease | http://purl.obolibrary.org/obo/MONDO_0003847 |
T20 | 1802-1805 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T21 | 1826-1835 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 262-271 | Body_part | denotes | organisms | http://purl.obolibrary.org/obo/UBERON_0000468 |
T2 | 553-562 | Body_part | denotes | organisms | http://purl.obolibrary.org/obo/UBERON_0000468 |
T3 | 677-689 | Body_part | denotes | neural cells | http://purl.obolibrary.org/obo/CL_0002319 |
T4 | 867-883 | Body_part | denotes | peripheral nerve | http://purl.obolibrary.org/obo/UBERON_0001021 |
T5 | 964-989 | Body_part | denotes | peripheral nervous system | http://purl.obolibrary.org/obo/UBERON_0000010 |
T6 | 991-994 | Body_part | denotes | PNS | http://purl.obolibrary.org/obo/UBERON_0000010 |
T7 | 1732-1742 | Body_part | denotes | lymphocyte | http://purl.obolibrary.org/obo/CL_0000542 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 283-303 | OrganismTaxon | denotes | Campylobacter jejuni | 197 |
T2 | 317-339 | OrganismTaxon | denotes | Haemophilus influenzae | 727 |
T3 | 345-360 | OrganismTaxon | denotes | Cytomegalovirus | 10358 |
T4 | 362-365 | OrganismTaxon | denotes | CMV | 10358 |
T5 | 495-500 | OrganismTaxon | denotes | human | 9606 |
T6 | 1726-1731 | OrganismTaxon | denotes | human | 9606 |
GlyCosmos15-CL
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 677-689 | Cell | denotes | neural cells | http://purl.obolibrary.org/obo/CL:0002319 |
T2 | 1732-1742 | Cell | denotes | lymphocyte | http://purl.obolibrary.org/obo/CL:0000542 |
GlyCosmos15-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 867-883 | Body_part | denotes | peripheral nerve | http://purl.obolibrary.org/obo/MAT_0000099 |
T2 | 964-989 | Body_part | denotes | peripheral nervous system | http://purl.obolibrary.org/obo/MAT_0000338 |
T3 | 991-994 | Body_part | denotes | PNS | http://purl.obolibrary.org/obo/MAT_0000338 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-123 | Sentence | denotes | Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. |
TextSentencer_T2 | 124-240 | Sentence | denotes | Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. |
TextSentencer_T3 | 241-425 | Sentence | denotes | Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. |
TextSentencer_T4 | 426-583 | Sentence | denotes | Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. |
TextSentencer_T5 | 584-764 | Sentence | denotes | Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. |
TextSentencer_T6 | 765-916 | Sentence | denotes | Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. |
TextSentencer_T7 | 917-1069 | Sentence | denotes | Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. |
TextSentencer_T8 | 1070-1279 | Sentence | denotes | Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. |
TextSentencer_T9 | 1280-1503 | Sentence | denotes | The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. |
TextSentencer_T10 | 1504-1651 | Sentence | denotes | Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. |
TextSentencer_T11 | 1652-1836 | Sentence | denotes | While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection. |
T1 | 0-123 | Sentence | denotes | Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. |
T2 | 124-240 | Sentence | denotes | Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. |
T3 | 241-425 | Sentence | denotes | Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. |
T4 | 426-583 | Sentence | denotes | Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. |
T5 | 584-764 | Sentence | denotes | Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. |
T6 | 765-916 | Sentence | denotes | Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. |
T7 | 917-1069 | Sentence | denotes | Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. |
T8 | 1070-1279 | Sentence | denotes | Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. |
T9 | 1280-1503 | Sentence | denotes | The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. |
T10 | 1504-1651 | Sentence | denotes | Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. |
T11 | 1652-1836 | Sentence | denotes | While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection. |
T1 | 0-123 | Sentence | denotes | Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. |
T2 | 124-240 | Sentence | denotes | Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. |
T3 | 241-425 | Sentence | denotes | Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. |
T4 | 426-583 | Sentence | denotes | Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. |
T5 | 584-764 | Sentence | denotes | Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. |
T6 | 765-916 | Sentence | denotes | Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. |
T7 | 917-1069 | Sentence | denotes | Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. |
T8 | 1070-1279 | Sentence | denotes | Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. |
T9 | 1280-1503 | Sentence | denotes | The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. |
T10 | 1504-1651 | Sentence | denotes | Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. |
T11 | 1652-1836 | Sentence | denotes | While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-123 | Sentence | denotes | Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. |
T2 | 124-240 | Sentence | denotes | Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. |
T3 | 241-425 | Sentence | denotes | Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. |
T4 | 426-583 | Sentence | denotes | Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. |
T5 | 584-764 | Sentence | denotes | Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. |
T6 | 765-916 | Sentence | denotes | Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. |
T7 | 917-1069 | Sentence | denotes | Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. |
T8 | 1070-1279 | Sentence | denotes | Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. |
T9 | 1280-1503 | Sentence | denotes | The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. |
T10 | 1504-1651 | Sentence | denotes | Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. |
T11 | 1652-1836 | Sentence | denotes | While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1199-1203 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
T2 | 1208-1212 | Glycan | denotes | GD1b | https://api.glycosmos.org/wurcs2image/latest/png/binary/G37184KW |
T3 | 1217-1220 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T4 | 1225-1229 | Glycan | denotes | GD1a | https://api.glycosmos.org/wurcs2image/latest/png/binary/G46677TE |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 1199-1203 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
T2 | 1208-1212 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1b | http://www.glycoepitope.jp/epitopes/EP0059 |
T3 | 1217-1220 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T4 | 1225-1229 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 283-303 | OrganismTaxon | denotes | Campylobacter jejuni | 197 |
T2 | 317-339 | OrganismTaxon | denotes | Haemophilus influenzae | 727 |
T3 | 345-360 | OrganismTaxon | denotes | Cytomegalovirus | 10358 |
T4 | 362-365 | OrganismTaxon | denotes | CMV | 10358 |
T5 | 495-500 | OrganismTaxon | denotes | human | 9606 |
T6 | 1726-1731 | OrganismTaxon | denotes | human | 9606 |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 1199-1203 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
T2 | 1208-1212 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1b | http://www.glycoepitope.jp/epitopes/EP0059 |
T3 | 1217-1220 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T4 | 1225-1229 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GD1a | http://www.glycoepitope.jp/epitopes/EP0056 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 262-271 | Body_part | denotes | organisms | http://purl.obolibrary.org/obo/UBERON_0000468 |
T2 | 553-562 | Body_part | denotes | organisms | http://purl.obolibrary.org/obo/UBERON_0000468 |
T3 | 677-689 | Body_part | denotes | neural cells | http://purl.obolibrary.org/obo/CL_0002319 |
T4 | 867-883 | Body_part | denotes | peripheral nerve | http://purl.obolibrary.org/obo/UBERON_0001021 |
T5 | 964-989 | Body_part | denotes | peripheral nervous system | http://purl.obolibrary.org/obo/UBERON_0000010 |
T6 | 991-994 | Body_part | denotes | PNS | http://purl.obolibrary.org/obo/UBERON_0000010 |
T7 | 1732-1742 | Body_part | denotes | lymphocyte | http://purl.obolibrary.org/obo/CL_0000542 |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 867-883 | Body_part | denotes | peripheral nerve | http://purl.obolibrary.org/obo/MAT_0000099 |
T2 | 964-989 | Body_part | denotes | peripheral nervous system | http://purl.obolibrary.org/obo/MAT_0000338 |
T3 | 991-994 | Body_part | denotes | PNS | http://purl.obolibrary.org/obo/MAT_0000338 |
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 677-689 | Cell | denotes | neural cells | http://purl.obolibrary.org/obo/CL:0002319 |
T2 | 1732-1742 | Cell | denotes | lymphocyte | http://purl.obolibrary.org/obo/CL:0000542 |